Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (11317)	8/17/1999 11:27:00 AM
From: Cacaito	Read Replies (2) \| Respond to of 17367

At best, a very poor "pr"; at worst, a probable deception. Someone at yahoo said that spoke to Ellen and she claims she was taken out of context by the journalist. Of course, the deception could be from the journalist or probably from someone at Xoma. Also, Ellen claims she was talking about the stock uncertainties, not the fda,trial,bpi,results. If this is so, Why is Ellen making comments about the stock price to an obscure journalist? The CEO did not talk about the stock price, and Ellen does? Ellen M. Martin at best is not capable of her job. She causes a market value drop of some $150 millions and she was taken out of context? This is ridiculous. This is from yahoo references, no way to confirm anything as actually told by Ellen M. Martin. I had a position in this company, now I am out completely. Best case: they do not care at all. The Class action suits is the next "PR" to handle.